<--- Back to Details
First PageDocument Content
Pharmacology / Clinical research / Drug safety / Pharmaceuticals policy / Pharmaceutical industry / European Medicines Agency / Pharmacovigilance / EudraVigilance / Adverse effect / Health / Pharmaceutical sciences / Medicine
Date: 2014-08-06 05:36:48
Pharmacology
Clinical research
Drug safety
Pharmaceuticals policy
Pharmaceutical industry
European Medicines Agency
Pharmacovigilance
EudraVigilance
Adverse effect
Health
Pharmaceutical sciences
Medicine

Pharmacovigilance Programme Update - Issue 1

Add to Reading List

Source URL: www.ema.europa.eu

Download Document from Source Website

File Size: 786,75 KB

Share Document on Facebook

Similar Documents

PDF Document

DocID: 1xvUb - View Document

PDF Document

DocID: 1xc8R - View Document

Institute of Pharmacology www.pki.unibe.ch Introduction Prof. Dr. Dr. Stephan von Gunten MD PhD MME

DocID: 1vqsj - View Document

Jansone et al.: Intrinsic Activity, 2017; 5 (Suppl.2):A1.6 doi:IA.5.S2-A1.6 published online: 16 October 2017 2nd International Conference in Pharmacology: From Cellular Processes to Drug Targets Rīga, Latvia

DocID: 1vlJU - View Document

Human cells Notable for research in: -Medecine: Diseases and cancers -Cell Biology -Pharmacology

DocID: 1vk1K - View Document